GOVX:NASDAQ
Geovax Labs Inc
$0.28
arrow_downward
-1.95%(-0.0056) 1D
$0.28
arrow_downward
-0.04% (-0.000100)bedtimeAfter hours
Closed: Oct 9, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GOVX...
Open
$0.28
High
$0.30
Low
$0.27
Mkt. cap
2.53M
Avg. vol.
870.99K
Volume
233.07K
52-wk high
$15.75
52-wk low
$0.27
EPS
-$13.92
Beta
3.69
Shares outstanding
10.10M
No. of employees
19
Open
$0.28
High
$0.30
Low
$0.27
Mkt. cap
2.53M
Avg. vol.
870.99K
Volume
233.07K
52-wk high
$15.75
52-wk low
$0.27
EPS
-$13.92
Beta
3.69
Shares outstanding
10.10M
No. of employees
19
News stories
From web sources and news partners
https://www.dars.gov.et/
·
2 months ago
GOVX Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Market Reaction - Margin Compression Risk
Profile
GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated. Wikipedia
About Geovax Labs Inc
CEODavid A. Dodd
Employees19
Founded1988
HeadquartersAtlanta, Georgia, United States
SectorBiotechnology
Websitegeovax.com